Vanguard Capital Management’s Health Catalyst HCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.91M Buy
2,971,598
+85,945
+3% +$124K ﹤0.01% 3055
2026
Q1
$3.66M Buy
+2,885,653
New +$5.43M ﹤0.01% 3170

Other funds holding HCAT

Vanguard Capital Management's HCAT Position: Q2 2026 in Review

Vanguard Capital Management increased its Health Catalyst (HCAT) stake by 3% in Q2 2026, buying an estimated $124K and bringing the position to 2,971,598 shares worth $5.91M. The position accounts for ﹤0.01% of the portfolio, ranked #3055.

Vanguard Capital Management first reported a position in HCAT in Q1 2026 and has held it in 2 quarters since. 127 funds tracked by Wall St. Rank hold HCAT as of Q2 2026.

  • Vanguard Capital Management held 2,971,598 shares of Health Catalyst worth $5.91M as of Q2 2026.
  • Vanguard Capital Management bought 85,945 Health Catalyst shares in Q2 2026, an estimated $124K.
  • Health Catalyst made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #3055 holding.
  • Vanguard Capital Management first reported a position in Health Catalyst in Q1 2026 and has held it in 2 quarters since.
  • 127 funds tracked by Wall St. Rank held Health Catalyst as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.